Jeffrey S. Bornstein's Insider Trades & SAST Disclosures
Jeffrey S. Bornstein's most recent trade in Eos Energy Enterprises Inc - Ordinary Shares - Class A was a trade of 105,263 Restricted Stock Units done . Disclosure was reported to the exchange on May 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey S. Bornstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 105,263 | 0 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2025 | 105,263 | 190,192 | - | 0 | Common Stock | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Sale or transfer of securities back to the company at price $ 6.94 per share. | 14 May 2025 | 42,105 | 148,087 | - | 6.9 | 292,209 | Common Stock |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Sale of securities on an exchange or to another person at price $ 2.63 per share. | 12 Sep 2024 | 132,720 | 7,999 | - | 2.6 | 349,054 | Common Stock |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Sale of securities on an exchange or to another person at price $ 2.62 per share. | 12 Sep 2024 | 30,000 | 84,929 | - | 2.6 | 78,600 | Common Stock |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 105,263 | 105,263 | - | - | Restricted Stock Units | |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 110,197 | - | 0 | Common Stock | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 32,328 | 114,929 | - | 0 | Common Stock | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 32,328 | 0 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 120,633 | 120,633 | - | - | Stock Option (Right to Buy) | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 32,328 | 32,328 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 52,601 | 0 | - | - | Restricted Stock Units | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 52,601 | 82,601 | - | 0 | Common Stock | |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 35,000 | 75,197 | - | 0 | Common Stock | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Purchase of securities on an exchange or from another person at price $ 1.30 per share. | 10 Nov 2022 | 20,000 | 20,000 | - | 1.3 | 25,936 | Common Stock |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 80,116 | 80,116 | - | - | Stock Option (Right to Buy) | |
| Eos Energy Enterprises Inc... | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Sep 2022 | 52,632 | 52,632 | - | - | Restricted Stock Units | |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 27,500 | 27,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Purchase of securities on an exchange or from another person at price $ 4.64 per share. | 26 Apr 2022 | 5,000 | 40,197 | - | 4.6 | 23,197 | Common Stock |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Purchase of securities on an exchange or from another person at price $ 8.87 per share. | 10 Feb 2022 | 5,000 | 35,197 | - | 8.9 | 44,350 | Common Stock |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Sale of securities on an exchange or to another person at price $ 40.39 per share. | 18 Feb 2021 | 19,771 | 812 | - | 40.4 | 798,606 | Common Stock |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Sale of securities on an exchange or to another person at price $ 41.27 per share. | 18 Feb 2021 | 812 | 0 | - | 41.3 | 33,513 | Common Stock |
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | 03 Aug 2020 | 30,674 | 0 | - | - | Series B Preferred Convertible Stock | ||
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | 03 Aug 2020 | 20,583 | 20,583 | - | - | Common Stock | ||
| Kalaris Therapeutics Inc. | Jeffrey S. Bornstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2020 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges